COM

ALEXION PHARMACEUTICALS INC. PAC

PAC (qualified). Lobbyist or registrant PAC.

PAC (qualified)Lobbyist or registrant PACMixed activity · 48% Democratic / 52% Republican · 0% unclassifiedInferred from activityMonthly filer

Financial snapshot

FEC bulk summary totals through Dec 31, 2024

Total receipts$155.1K

FEC reported disbursements$153.3KReported total may include noncash accounting entries

Individual contributions$155.1K

FEC reported cash on hand$203.1K

Coverage Not reported to Dec 31, 2024Contribution refunds $38Debts owed by committee $0Last report Not reported

Candidate connections

Candidate identity and documented relationships · 2023–2024

Candidate campaign receiving transfers
AGUILAR, PETEDemocraticFEC reported
U.S. House · California · District 33
Election 2024 · Incumbent · Current candidate
Receiving campaign: PETE AGUILAR FOR CONGRESS
Candidate details & sources
FEC candidate ID: H2CA31125 · 2023–2024 reporting cycle
Candidate campaign receiving transfers
BILIRAKIS, GUS M

Registration details

Locally ingested FEC master-file snapshot for 2023–2024

Committee type: PAC (qualified)
Designation: Lobbyist or registrant PAC
Party affiliation: No party affiliation reported
Treasurer: SPALDING, TODD
Filing cadence: Monthly filer
Organization type: Corporation
Connected organization: ALEXION PHARMACEUTICALS INC.
Cycles loaded: 2026, 2024
Registered address: 801 PENNSYLVANIA AVE NW · STE 400 · WASHINGTON, DC, 20004

Political alignment

Registration, linked-candidate, and disclosed money-flow evidence

Evidence-based classificationMixed activity · 48% Democratic / 52% Republican · 0% unclassifiedMixed activity · 48% Democratic / 52% Republican · 0% unclassifiedInferred from activity

FEC registration: PAC (qualified); no party affiliation reported. Classification basis: Inferred from activity. This describes disclosed financial activity, not an official party registration or ideological score. The figures below separately preserve the filer’s Schedule E support and opposition designations.

No candidate support/oppose spending foundThis cycle has no locally ingested Schedule E rows for this committee. Registration, linked-candidate, committee-transfer, and recipient-reported conduit evidence can still establish the alignment shown above.

$0 supporting · $0 opposing · 0 rowsOfficial FEC outside spending ↗

Source & provenance

Trace this profile back to the public record

Source agencyFederal Election Commission

Local row ingestedSep 4, 2026

Source row hash349a50e98b022e8ee7698ee5a59b8ea3216a7fe4174e1ea92a5ca4eeedae1703

View official FEC record

Financial figures are processed FEC totals and may change when amended reports are filed. Registration fields preserve raw master-file values loaded for the 2023–2024 snapshot.

Contributor	Reported context	Date	Election	Amount	FEC record
PHILIP, NAOMI`View reported donor profile →`Supports 48% Democratic / 52% Republican · 0% unclassifiedDerived from contributionsNEW HAVEN CT 06510	RESEARCH SCIENTIST I IVIVP ALEXION PHARMACEUTICALSM7	Jun 2, 2023	Primary (P)	$500	Original filing ↗
CHENG, SENG`View reported donor profile →`Supports 48% Democratic / 52% Republican · 0% unclassifiedDerived from contributionsBOSTON MA 02210	SENIOR VICE PRESIDENT HEAD OF RESEARC ALEXION PHARMACEUTICALSM3	Feb 29, 2024	Primary (P)	$260	Original filing ↗
DUGGAN, RHONDA`View reported donor profile →`Supports 48% Democratic / 52% Republican · 0% unclassifiedDerived from contributionsCONCORD NC 28025	PATIENT EDUCATION MANAGER COMPLEMENT ALEXION PHARMACEUTICALSM5	Apr 15, 2024	Primary (P)	$250	Original filing ↗
SIMPSON, NIPAR`View reported donor profile →`Supports 48% Democratic / 52% Republican · 0% unclassifiedDerived from contributionsNEW HAVEN CT 06510	SENIOR SPECIALIST EXTERNAL QUALITY ALEXION PHARMACEUTICALSM9	Aug 15, 2024	Primary (P)	$240	Original filing ↗
ORZECHOWSKI, MARTHA`View reported donor profile →`Supports 48% Democratic / 52% Republican · 0% unclassifiedDerived from contributionsNEW HAVEN CT 06510	HEAD OF GLOBAL PATIENT ADVOCACY US ALEXION PHARMACEUTICALS12G	Oct 15, 2024	Primary (P)	$208	Original filing ↗
OLESKE, DENISE`View reported donor profile →`Supports 48% Democratic / 52% Republican · 0% unclassifiedDerived from contributionsNEW HAVEN CT 06510	SENIOR DIRECTOR EPIDEMIOLOGY ALEXION PHARMACEUTICALS12G	Oct 15, 2024	Primary (P)	$208	Original filing ↗
ORZECHOWSKI, MARTHA`View reported donor profile →`Supports 48% Democratic / 52% Republican · 0% unclassifiedDerived from contributionsNEW HAVEN CT 06510	HEAD OF GLOBAL PATIENT ADVOCACY US ALEXION PHARMACEUTICALSM10	Sep 30, 2024	Primary (P)	$208	Original filing ↗
ORZECHOWSKI, MARTHA`View reported donor profile →`Supports 48% Democratic / 52% Republican · 0% unclassifiedDerived from contributionsNEW HAVEN CT 06510	HEAD OF GLOBAL PATIENT ADVOCACY US ALEXION PHARMACEUTICALSM10	Sep 13, 2024	Primary (P)	$208	Original filing ↗
OLESKE, DENISE`View reported donor profile →`Supports 48% Democratic / 52% Republican · 0% unclassifiedDerived from contributionsNEW HAVEN CT 06510	SENIOR DIRECTOR EPIDEMIOLOGY ALEXION PHARMACEUTICALSM10	Sep 30, 2024	Primary (P)	$208	Original filing ↗
OLESKE, DENISE`View reported donor profile →`Supports 48% Democratic / 52% Republican · 0% unclassifiedDerived from contributionsNEW HAVEN CT 06510	SENIOR DIRECTOR EPIDEMIOLOGY ALEXION PHARMACEUTICALSM10	Sep 13, 2024	Primary (P)	$208	Original filing ↗

Recipient	Purpose	Date	Amount	FEC record
MATSUI FOR CONGRESS`C00409219`SACRAMENTO, CA	24KM4 24KLinked: C00409219	Mar 23, 2023	$5,000	FEC disbursement search ↗
CATHY MCMORRIS RODGERS FOR CONGRESS`C00390476`SPOKANE, WA	24KM4 24KLinked: C00390476	Mar 8, 2023	$5,000	FEC disbursement search ↗
MASSACHUSETTS BIOTECHNOLOGY COUNCIL INC. FEDERAL POLITICAL ACTION COMMITTEE`C00380733`CAMBRIDGE, MA	24KM4 24KLinked: C00380733	Mar 18, 2024	$5,000	FEC disbursement search ↗

ALEXION PHARMACEUTICALS INC. PAC

Financial snapshot

Candidate connections

Registration details

Political alignment

Source & provenance

FEC-reported relationships

Money network

Cash, assets & liabilities

Receipts

Contribution breakdowns

Largest itemized receipts

Disbursements

Largest disbursements

Loans, debts & allocations

Reports & filings